Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Purified human basophils do not generate LTB4.

J A Warner1, H S Freeland, D W MacGlashan

  • 1Department of Medicine, Johns Hopkins University School of Medicine, Good Samaritan Hospital, Baltimore, MD 21239.

Biochemical Pharmacology
|October 1, 1987
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Recovery from desensitization of IgE-dependent responses in human lung mast cells.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2017
Same author

Airway and peripheral urokinase plasminogen activator receptor is elevated in asthma, and identifies a severe, nonatopic subset of patients.

Allergy·2016
Same author

Strain-induced crack formations in PDMS/DXA drug collars.

Acta biomaterialia·2013
Same author

Cat allergen-induced blood basophil reactivity in vitro predicts acute human nasal allergen challenge responses in vivo.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2011
Same author

Characterization of syk expression in human lung mast cells: relationship with function.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2011
Same author

Role of alpha5 nicotinic acetylcholine receptors in pharmacological and behavioral effects of nicotine in mice.

The Journal of pharmacology and experimental therapeutics·2010
Same journal

IGFBP5 suppresses colorectal cancer stemness and carcinogenesis via binding to GPR182 and inhibiting PKCα/AKT/P70S6K axis.

Biochemical pharmacology·2026
Same journal

Activation of GABA<sub>B</sub>R alleviates colitis by reprogramming macrophage polarization via the IRAK-M/NLRP3/NF-κB pathway.

Biochemical pharmacology·2026
Same journal

Revisiting pharmacological actions of disodium cromoglycate in light of GPR35: New therapeutic contexts for classical drugs.

Biochemical pharmacology·2026
Same journal

Dysregulation of the bile acid signaling network in non-alcoholic fatty liver disease: Mechanisms and a new paradigm of precision network pharmacology.

Biochemical pharmacology·2026
Same journal

hIMB1636-LDM, a novel anti-TROP2 ADC, exerts potent antitumor efficacy in pancreatic cancer via direct cytotoxicity and immune activation.

Biochemical pharmacology·2026
Same journal

CD55 glycosylation promotes ferroptotic stress tolerance in CD55-high triple-negative breast cancer.

Biochemical pharmacology·2026
See all related articles

Human basophils release leukotriene C4 (LTC4) but not leukotriene B4 (LTB4) upon IgE-mediated stimulation. Monocyte contamination, not basophils, is responsible for LTB4 synthesis in these experiments.

Area of Science:

  • Immunology
  • Cell Biology
  • Biochemistry

Background:

  • Arachidonic acid (AA) metabolism generates 5-lipoxygenase (5-LO) derivatives, including leukotrienes (LTs).
  • Leukotriene B4 (LTB4) is a potent chemoattractant, while leukotriene C4 (LTC4) is a precursor to other LTs involved in allergic inflammation.
  • Human basophils and mast cells are key effector cells in allergic responses, releasing inflammatory mediators.

Purpose of the Study:

  • To investigate the release of 5-lipoxygenase derivatives of arachidonic acid (AA) in purified human basophils.
  • To compare the release of LTB4 and LTC4 from human basophils with human lung mast cells.
  • To determine the role of basophils versus contaminating cells in LTB4 synthesis.

Main Methods:

  • Purification of human basophils and assessment of purity.

Related Experiment Videos

  • Challenge of purified basophils with anti-IgE (specific stimulus) and A23187 (non-specific stimulus).
  • Measurement of histamine, LTB4, and LTC4 release using immunological assays and radiolabeling with [3H]AA.

    • Main Results:

    • Purified basophils released histamine and LTC4 upon anti-IgE challenge but not LTB4.
    • Non-specific stimulation with A23187 induced release of histamine, LTC4, and LTB4.
    • LTB4 release correlated inversely with basophil purity, implicating contaminating monocytes in LTB4 synthesis.
    • Human lung mast cells released significantly less LTB4 compared to basophils after IgE-mediated challenge.
    • No intracellular LTB4 was detected in basophil pellets, and exogenously added LTB4 was not metabolized.

    Conclusions:

    • Human basophils primarily release LTC4, not LTB4, following IgE-mediated activation.
    • Monocytes, not basophils, are the main source of LTB4 production in these experimental conditions.
    • These findings clarify the specific roles of basophils in the production of AA derivatives during allergic inflammation.